Skip to search formSkip to main contentSkip to account menu

vintoperol

Known as: 1-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizine-1-methanol 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

IndolesQuinolizines

Narrower (2)

RGH 2981RT 3003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Composition medicinale contenant du vintoperol destinee a une administration transdermique
L'invention concerne une composition medicinale contenant du vintoperol, caracterisee en ce qu'elle presente ses effets sur une… 
2002
2002
[Investigation of vasoactive agents with indole skeletons at Richter Ltd].
Investigation of agents with indol skeleton was started in Richter Ltd. 50 years ago. This paper presents the results obtained by… 
1999
1999
Key fragments for identification of positional isomer pair in glucuronides from the hydroxylated metabolites of RT-3003 (Vintoperol) by liquid chromatography/electrospray ionization mass spectrometry…
The mass spectral properties of glucuronides of the 9- and 10-hydroxylated metabolites of RT-3003 (Vintoperol; (-)-1beta-ethyl… 
1994
1994
Effect of vintoperol on platelet aggregation and experimental thrombosis.
The platelet aggregation inhibitory and antithrombotic effect of the new peripheral circulation enhancing compound vintoperol… 
1992
1992
Involvement of Endothelium in Vasodilating Effects of Vintoperol
Summary: Experiments were performed on vessels of the femoral vascular bed of anesthetized dogs and on isolated rings of the rat… 
1992
1992
[The role of the endothelium in the vascular effects of vintoperol].
The effects of vintoperol have been studied in the experiments on the vascular bed of femoral artery of 15 mongrel dogs under… 
1991
1991
Vasodilator and angioprotective activity of 1-ethyl-1-hydroxyalkyl-octahydroindolo[2,3a]quinolizine derivates.
The blood flow enhancing activity of the homologue series of "trans" racemic 1-ethyl-1-hydroxyalkyl-1,2,3,4,6,7,12,12b… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)